Dazukibart
Pfizer
['derm']
medscape: a monoclonal antibody targeting ifn-beta provided substantial reductions in the skin lesions associated with dermatomyositis in a double-blind, placebo-controlled phase 2 trial. #aad2023 #dermtwitter 
Make life a little bit more cheerful is my main goal. I love to laugh, make people happy, and share interesting articles about health.